Found: 12
Select item for more details and to access through your institution.
Evaluation of Drug—Drug Interactions in EGFR-Mutated Non-Small-Cell Lung Cancer Patients during Treatment with Tyrosine-Kinase Inhibitors.
- Published in:
- Journal of Personalized Medicine, 2021, v. 11, n. 5, p. 424, doi. 10.3390/jpm11050424
- By:
- Publication type:
- Article
Circulating CD81-expressing extracellular vesicles as biomarkers of response for immune-checkpoint inhibitors in advanced NSCLC.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.987639
- By:
- Publication type:
- Article
Circulating CD81-expressing extracellular vesicles as biomarkers of response for immune-checkpoint inhibitors in advanced NSCLC.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.987639
- By:
- Publication type:
- Article
Immune-Checkpoint Inhibitors in Advanced Non-Small Cell Lung Cancer With Uncommon Histology.
- Published in:
- Clinical Lung Cancer, 2022, v. 23, n. 1, p. e17, doi. 10.1016/j.cllc.2021.06.013
- By:
- Publication type:
- Article
Steroid Use Independently Predicts for Poor Outcomes in Patients With Advanced NSCLC and High PD-L1 Expression Receiving First-Line Pembrolizumab Monotherapy.
- Published in:
- 2021
- By:
- Publication type:
- journal article
DiM: Prognostic Score for Second- or Further-line Immunotherapy in Advanced Non-Small-Cell Lung Cancer: An External Validation.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Machine Learning Using Real-World and Translational Data to Improve Treatment Selection for NSCLC Patients Treated with Immunotherapy.
- Published in:
- Cancers, 2022, v. 14, n. 2, p. 435, doi. 10.3390/cancers14020435
- By:
- Publication type:
- Article
Beyond First-Line Immunotherapy: Potential Therapeutic Strategies Based on Different Pattern Progressions: Oligo and Systemic Progression.
- Published in:
- Cancers, 2021, v. 13, n. 6, p. 1300, doi. 10.3390/cancers13061300
- By:
- Publication type:
- Article
Association of Steroids Use with Survival in Patients Treated with Immune Checkpoint Inhibitors: A Systematic Review and Meta-Analysis.
- Published in:
- Cancers, 2020, v. 12, n. 3, p. 546, doi. 10.3390/cancers12030546
- By:
- Publication type:
- Article
Impact of performance status on non-small-cell lung cancer patients with a PD-L1 tumour proportion score ≥50% treated with front-line pembrolizumab.
- Published in:
- Acta Oncologica, 2020, v. 59, n. 9, p. 1058, doi. 10.1080/0284186X.2020.1781249
- By:
- Publication type:
- Article
Real-world data to build explainable trustworthy artificial intelligence models for prediction of immunotherapy efficacy in NSCLC patients.
- Published in:
- Frontiers in Oncology, 2023, v. 13, p. 1, doi. 10.3389/fonc.2022.1078822
- By:
- Publication type:
- Article
Case Report: Exceptional Response to Poziotinib in Patient with Metastatic Non-Small Cell Lung Cancer With EGFR Exon 20 Insertion Mutation.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.902967
- By:
- Publication type:
- Article